FDA Approves Lorbrena as First-Line Treatment for ALK-Positive Non-Small Cell Lung Cancer
Imbruvica Plus Novel Agent May Improve Progression-Free Survival in Chronic Lymphocytic Leukemia
How Caregivers Can Become an Active Part of the Cancer Care Team
Strict Cleaning Protocols Induce Limited Traces of Virus That Causes COVID-19 in Cancer Centers